Health-related quality-of-life analysis from KEYNOTE-045: a phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer
- David J. Vaughn*
- , Joaquim Bellmunt
- , Yves Fradet
- , Jae Lyun Lee
- , Lawrence Fong
- , Nicholas J. Vogelzang
- , Miguel A. Climent
- , Daniel P. Petrylak
- , Toni K. Choueiri
- , Andrea Necchi
- , Winald Gerritsen
- , Howard Gurney
- , David I. Quinn
- , Stephane Culine
- , Cora N. Sternberg
- , Yabing Mai
- , Haojie Li
- , Rodolfo F. Perini
- , Dean F. Bajorin
- , Ronald de Wit
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
108
Link opens in a new tab
Citations
(Scopus)